JP2012532901A5 - - Google Patents

Download PDF

Info

Publication number
JP2012532901A5
JP2012532901A5 JP2012519902A JP2012519902A JP2012532901A5 JP 2012532901 A5 JP2012532901 A5 JP 2012532901A5 JP 2012519902 A JP2012519902 A JP 2012519902A JP 2012519902 A JP2012519902 A JP 2012519902A JP 2012532901 A5 JP2012532901 A5 JP 2012532901A5
Authority
JP
Japan
Prior art keywords
het
atoms
nha
proportions
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012519902A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532901A (ja
Filing date
Publication date
Priority claimed from DE102009033392A external-priority patent/DE102009033392A1/de
Application filed filed Critical
Publication of JP2012532901A publication Critical patent/JP2012532901A/ja
Publication of JP2012532901A5 publication Critical patent/JP2012532901A5/ja
Pending legal-status Critical Current

Links

JP2012519902A 2009-07-16 2010-06-17 オートタキシン阻害剤としての複素環式化合物 Pending JP2012532901A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102009033392A DE102009033392A1 (de) 2009-07-16 2009-07-16 Heterocyclische Verbindungen als Autotaxin-Inhibitoren II
DE102009033392.4 2009-07-16
PCT/EP2010/003661 WO2011006569A1 (de) 2009-07-16 2010-06-17 Heterocyclische verbindungen als autotaxin-inhibitoren

Publications (2)

Publication Number Publication Date
JP2012532901A JP2012532901A (ja) 2012-12-20
JP2012532901A5 true JP2012532901A5 (OSRAM) 2013-08-08

Family

ID=42646326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012519902A Pending JP2012532901A (ja) 2009-07-16 2010-06-17 オートタキシン阻害剤としての複素環式化合物

Country Status (16)

Country Link
US (1) US20120115852A1 (OSRAM)
EP (1) EP2454258A1 (OSRAM)
JP (1) JP2012532901A (OSRAM)
KR (1) KR20120090031A (OSRAM)
CN (1) CN102471343A (OSRAM)
AR (1) AR077488A1 (OSRAM)
AU (1) AU2010272922A1 (OSRAM)
BR (1) BR112012000792A2 (OSRAM)
CA (1) CA2768095A1 (OSRAM)
DE (1) DE102009033392A1 (OSRAM)
EA (1) EA201200119A1 (OSRAM)
IL (1) IL217466A0 (OSRAM)
MX (1) MX2012000609A (OSRAM)
SG (1) SG177522A1 (OSRAM)
WO (1) WO2011006569A1 (OSRAM)
ZA (1) ZA201201124B (OSRAM)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2861566T (pt) 2012-06-13 2017-02-08 Hoffmann La Roche Novos diazaspirocicloalcanos e azaspirocicloalcanos
AU2013322838B2 (en) * 2012-09-25 2018-02-01 F. Hoffmann-La Roche Ag New bicyclic derivatives
CN104968656B (zh) 2012-12-19 2017-08-11 诺华股份有限公司 自分泌运动因子抑制剂
US9409895B2 (en) 2012-12-19 2016-08-09 Novartis Ag Autotaxin inhibitors
AR095079A1 (es) * 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
TW201446768A (zh) * 2013-03-15 2014-12-16 Biogen Idec Inc S1p及/或atx調節劑
WO2015042053A1 (en) 2013-09-17 2015-03-26 Pharmakea, Inc. Vinyl autotaxin inhibitor compounds
US9951026B2 (en) 2013-09-17 2018-04-24 Pharmakea, Inc. Heterocyclic vinyl autotaxin inhibitor compounds
US9850203B2 (en) 2013-09-26 2017-12-26 Pharmakea, Inc. Autotaxin inhibitor compounds
US9926318B2 (en) 2013-11-22 2018-03-27 Pharmakea, Inc. Tetracyclic autotaxin inhibitors
WO2015077503A1 (en) 2013-11-22 2015-05-28 Pharmakea, Inc. Autotaxin inhibitor compounds
AU2014356583B2 (en) * 2013-11-26 2019-02-28 F. Hoffmann-La Roche Ag New octahydro-cyclobuta (1,2-c;3,4-c')dipyrrol-2-yl
WO2015144609A1 (en) * 2014-03-26 2015-10-01 F. Hoffmann-La Roche Ag Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
AU2015238537B2 (en) 2014-03-26 2019-08-01 F. Hoffmann-La Roche Ag Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
CR20160496A (es) 2014-04-04 2017-01-02 X-Rx Inc Inhibidores espirocíclicos sustituidos de la autotaxina
JP6592008B2 (ja) * 2014-04-23 2019-10-16 エックス−アールエックス, インコーポレイテッド オートタキシンの置換n−(2−アミノ)−2−オキソエチルベンズアミド阻害剤およびそれらの調製、ならびにlpa依存性またはlpa媒介性疾患の処置における使用
US9051320B1 (en) 2014-08-18 2015-06-09 Pharmakea, Inc. Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor
GB201501870D0 (en) 2015-02-04 2015-03-18 Cancer Rec Tech Ltd Autotaxin inhibitors
GB201502020D0 (en) 2015-02-06 2015-03-25 Cancer Rec Tech Ltd Autotaxin inhibitory compounds
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
AU2016268250B2 (en) 2015-05-27 2020-08-27 Sabre Therapeutics Llc Autotaxin inhibitors and uses thereof
US10118904B2 (en) 2015-06-05 2018-11-06 Vertex Pharmaceuticals Incorporated Triazoles for the treatment of Demyelinating Diseases
GB201510010D0 (en) 2015-06-09 2015-07-22 King S College London PDD and BPD compounds
US20180339985A1 (en) 2015-08-21 2018-11-29 Femtogenix Limited Pdd compounds
GB201514928D0 (en) 2015-08-21 2015-10-07 King S College London PDD compounds
UA123362C2 (uk) 2015-09-04 2021-03-24 Ф. Хоффманн-Ля Рош Аг Феноксиметильні похідні
CR20180057A (es) 2015-09-24 2018-04-02 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores duales de atx/ca.
AU2016328535A1 (en) 2015-09-24 2017-11-09 F. Hoffmann-La Roche Ag Bicyclic compounds as ATX inhibitors
KR20180053408A (ko) 2015-09-24 2018-05-21 에프. 호프만-라 로슈 아게 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서의 신규한 이환형 화합물
CR20180072A (es) 2015-09-24 2018-02-26 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores de atx
WO2018106646A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Aminotriazoles for the treatment of demyelinating diseases
WO2018106641A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Pyrazoles for the treatment of demyelinating diseases
WO2018106643A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Heterocyclic azoles for the treatment of demyelinating diseases
SG11201908560SA (en) 2017-03-16 2019-10-30 Hoffmann La Roche Heterocyclic compounds useful as dual atx/ca inhibitors
CN110382484B (zh) 2017-03-16 2022-12-06 豪夫迈·罗氏有限公司 新的作为atx抑制剂的二环化合物
JP6687816B1 (ja) * 2018-05-21 2020-04-28 株式会社アシックス ブラジャー
WO2020040326A1 (ko) * 2018-08-23 2020-02-27 가천대학교 산학협력단 페닐아세트산 유도체 및 이를 유효성분으로 함유하는 자가면역질환 예방 또는 치료용 조성물
US12048678B2 (en) * 2018-10-02 2024-07-30 Case Western Reserve University Compounds for treating myelin related disorders
WO2023154197A1 (en) * 2022-02-10 2023-08-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Fused diazepines as agonists of the insulin-like 3 (insl3) peptide receptor rxfp2 and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
ES2207333T7 (es) * 1999-01-19 2009-06-18 Orto-Mcneil Pharmaceutical, Inc. Benzodiazepinas triciclicas utilizadas como antagonistas del receptor de la vasopresina.
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
AU4972900A (en) 1999-04-08 2000-11-14 Arch Development Corporation Use of anti-vegf antibody to enhance radiation in cancer therapy
JP2003513940A (ja) * 1999-11-09 2003-04-15 ソシエテ・ド・コンセイユ・ド・ルシエルシエ・エ・ダアツプリカーション・シヤンテイフイツク・(エス.セー.エール.アー.エス) ヘテロ三量体gタンパク質情報の伝達抑制剤と他の抗癌剤とからなる、癌の処置において治療の目的に使用する製品

Similar Documents

Publication Publication Date Title
JP2012532901A5 (OSRAM)
JP2011530545A5 (OSRAM)
JP2010532768A5 (OSRAM)
JP2012506389A5 (OSRAM)
JP2015529229A5 (OSRAM)
AR077488A1 (es) Compuestos heterociclicos nitrogenados inhibidores de autotaxina, medicamentos que los contienen y uso de los mismos para el tratamiento y/o prevencion de cancer y enfermedades tumorales.
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
HRP20220886T1 (hr) Pripravci i postupci za proizvodnju pirimidina i spojeva piridina s btk inhibicijskom aktivnošću
JP2018510191A5 (OSRAM)
RU2016147727A (ru) Гетероциклилбутанамидные производные
JP2010532774A5 (OSRAM)
JP2012532899A5 (OSRAM)
JP2015524450A5 (OSRAM)
HRP20201681T1 (hr) Inhibitor aurora a kinaze
JP2018516963A5 (OSRAM)
JP2011510028A5 (OSRAM)
JP2014508811A5 (OSRAM)
RU2018116351A (ru) Пиримидиновое соединение
JP2016503799A5 (OSRAM)
JP2014518884A5 (OSRAM)
EA032971B1 (ru) Соль берберина и урсодезоксихолевой кислоты и ее применение
JP2017141277A5 (OSRAM)
RU2018106914A (ru) 1,3,4,-оксадизоламидное производное соединение в качестве ингибитора гистондеацетилазы 6 и содержащая его фармацевтическая композиция
RU2015115278A (ru) Производные гидропирролопиррола для применения в качестве ингибиторов синтазы жирных кислот
WO2014174524A8 (en) A novel composition for nonalcoholic fatty liver disease (nafld)